Clovis Oncology Denmark ApS — Credit Rating and Financial Key Figures

Clovis Oncology Denmark ApS (CVR number: 38721682K) is a company from ALLERØD. The company recorded a gross profit of 1656.3 kDKK in 2017. The operating profit was 58.7 kDKK, while net earnings were 54.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was 2.8 %, which can be considered weak but Return on Equity (ROE) was 52.1 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 3.9 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. Clovis Oncology Denmark ApS's liquidity measured by quick ratio was 1 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.